Long-Term Follow-Up of Patients with Metastatic Epidural Spinal Cord Compression from Solid Tumors Submitted for Surgery Followed by Radiation Therapy.

OBJECTIVE: To evaluate the outcome of patients with epidural spinal cord compression from different solid tumors treated with a combined approach, surgery plus radiotherapy (RT), with a follow-up longer than 10 years. METHODS: Ninety-seven patients treated between 2002 and 2009 were included. Surgical treatment was performed in patients with good performance status, limited metastatic disease, life expectancy longer than 3 months, and progressive neurologic deficit and/or intractable pain. RT was performed delivering a median total dose of 30 Gy in 10 fractions. Clinical outcome was evaluated using the modified visual analog scale for pain, the Frankel scale for neurologic deficit, and magnetic resonance imaging before treatment, after treatment, and every 3 months thereafter. RESULTS: Palliative decompression was performed in 27% of patients, tumor curettage (debulking) was performed in 51%, and total vertebrectomy was performed in 22%, followed by RT in 78% of cases. Pain remission was obtained in 98% of patients, and recovery of neurologic function was obtained in 51%. The median follow-up time was 135 months (range, 96-209 months). The 5- and 10-year local control rates were 82.8% and 82.8%, respectively. The median and 5- and 10-year progression-free survival rates were 12 months, 16.9%, and 11.3%, respectively; the median and 5- and 10-year overall survival rates were 18 months, 21.3%, and 12%, respectively. On univariate and multivariate analysis, factors recorded as conditioning survival were the performance status and the presence of other metastases at the time of vertebral treatment (P < 0.01). CONCLUSIONS: Our update confirmed that surgery plus RT is a safe and feasible treatment with limited morbidity. In selected patients with favorable prognostic factors, the combined treatment may significantly impact on survival.

Diagnosis and treatment of epidural metastases.

Epidural metastases occur in 5% to 10% of cancer patients and represent a neurological emergency. Patients most commonly present with an acute onset of motor weakness, and restoration of neurological function is critically dependent on prompt diagnosis and treatment. This review discusses the clinical, epidemiological, and radiological features associated with epidural metastases and resulting spinal cord compression. Moreover, current treatment paradigms are reviewed. The timely initiation of radiation as well as surgery in select cases is critical for preserving neurological function and achieving local tumor control and pain control. Future studies investigating surgical and radiation treatment for metastatic epidural cord compression are urgently needed. Cancer 2017;123:1106-1114. © 2016 American Cancer Society.

[Spinal tumors - part 1: extradural tumors. Epidemiology, clinical aspects and therapy]. / Spinale Tumoren - Teil 1: Extradurale Tumoren. Epidemiologie, klinische Aspekte und Therapie.

Spinal tumors are classified according to their location in extradural, intradural-extramedullary, and intradural-intramedullary tumors. The most frequent extradural tumors are metastases. Primary spinal tumors are rare and predominantly benign. Independent of their origin, spinal tumors manifest themselves with progressive local or radicular pain and neurological deficits. A preferably early diagnosis and subsequent therapy is important to improve the prognosis. The treatment of choice for most of these tumors is the complete surgical resection. In particular with the occurrence of neurological deficits a fast surgical intervention is indicated, since the prognosis depends on duration and severity of the preoperative existing deficits. Below, clinical presentation and relevant treatment options of spinal extradural tumors are discussed.

Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster Group Report.

PURPOSE: We analyzed the prevalence, clinical pattern, and prognostic impact of CNS involvement in a large cohort of children and adolescents diagnosed with non-Hodgkin's lymphoma (NHL), with special attention to differences according to NHL subtype. PATIENTS AND METHODS: From October 1986 to December 2002, 2,381 patients (median age, 9.37 years; range, 0.2 to 23.8 years; female-to-male ratio, 1:2.7) from Germany, Austria, and Switzerland were registered. A total of 2,086 patients were eligible for the consecutive multicenter protocols NHL-Berlin-Frankfurt-Münster [BFM] -86, NHL-BFM-90, and NHL-BFM-95, and could be evaluated for outcome. RESULTS: CNS involvement was diagnosed in 141 (5.9%) of 2,381 patients and was associated with an advanced stage of NHL. The percentage of CNS-positive patients was 8.8% for Burkitt's lymphoma/Burkitt's leukemia (BL/B-ALL), 5.4% for precursor B-lymphoblastic lymphoma (pB-LBL), 3.3% for anaplastic large-cell lymphoma, 3.2% for T-cell-LBL, 2.6% for diffuse large B-cell lymphoma, and 0% for primary mediastinal large B-cell NHL (P < .001). Most CNS-positive patients with pB-LBL, T-LBL, or BL/B-ALL had meningeal disease. The probability of event-free survival (pEFS; +/- SE) at 5 years was 85% +/- 1% for the 2,086 protocol patients (median follow-up, 6.5 years; range, 0.3 to 17.7 years). For the 112 CNS-positive patients, pEFS was 64% +/- 5%, compared with 86% +/- 1% for the 1,927 CNS-negative patients (P < .001). Although CNS disease had no impact on pEFS for advanced-stage T-LBL patients, CNS-positive patients with BL/B-ALL had a worse average outcome than CNS-negative patients with stage IV BL/B-ALL (60% +/- 5% v 81% +/- 3%; P < .001). In multivariate analysis, CNS disease was the strongest predictor for relapse in BL/B-ALL patients with advanced-stage disease. CONCLUSION: Six percent of childhood/adolescent NHL patients were CNS positive. However, the prevalence, pattern, and prognostic impact of CNS involvement differed among NHL subtypes.

Diretrizes no tratamento das metástases epidurais da coluna vertebral: atualização / Guidelines for treatment of epidural spinal metastases

Objetivo: Atualizar conceitos e recomendar condutas da prática médica nos aspectos de prognóstico,diagnóstico e tratamento das metástases epidurais da coluna vertebral. Método: O período de apuração das publicações situou-se entre janeiro de 1990 a janeiro de 2006, incluídas as referências relevantes prévias. A ausência de evidências de valor científico para determinar padrões ou diretrizes de conduta em temas médicos que geram incertezas da prática, permite usar do termo diretrizes para todas as recomendações. Resultados: A modalidade de tratamento a ser escolhido depende da análise dos fatores preditivos de prognóstico, tais como: o estado clínico do doente; a possibilidade de resgatar ou manter a capacidade de deambulação; grau de disseminação e transmissão da neoplasia primária.As informações obtidas com o diagnóstico de imagem da ressonância magnética efetuada em toda a extensão da coluna vertebral e o complemento das imagens ósseas pertinentes da tomografia axial computadorizada são necessárias na escolha e implementação do tratamento escolhido. O tratamento cirúrgico inclui a descompressão circunferencial da medula espinhal, a reconstrução do corpo vertebral e a estabilização segmentar da coluna vertebral. Conclusões: As recomendações conferem eficácia e eficiência nas condutas médicas. O prognóstico depende dos fatores preditivos de sobrevivência.Os exames complementares de imagem auxiliam no estadiamento e planejamento do tratamento.A modalidade de tratamento escolhida depende da previsão de sobrevivência e da capacidade de deambulação do doente.

Objective: Bring up-to-date concepts and conduct practice parameters recomendations concerningaspects in prognosis, diagnosis and treatment of spinal epidural metastases. Method: Pertinent publications between January, 1990 and January, 2006, including previous relevant medical articles were reviewed. The absence of scientific value for evidence to determine conduct standards or guidelines in uncertain medical practice allows to use as guideline all recomendations. Results: The choice of a treatment modality depends on predictive prognosis factors, such as: patient’s clinical state; preservation or salvage of walking capabilty; primary cancer spreading and transmission grade. Diagnostic information obtained by magnetic ressonance imaging of the spinal column complemented by pertinent computorized axial tomography bone images are necessary to choose and implement the treatment modality. Surgical treatment includes: circumferential spinal cord decompression; vertebral body reconstruction; segmental vertebral column stabilization. Conclusions: Recommendations bestow efficacy and efficiency of medical conducts. Complementary imaging studies are useful to determine the treatment, staging and planning. Treatment modality to be chosen depends on the patients’ survival expectancy and their capability to walk.

Cost-effectiveness of surgery plus radiotherapy versus radiotherapy alone for metastatic epidural spinal cord compression.

PURPOSE: A recent randomized clinical trial has demonstrated that direct decompressive surgery plus radiotherapy was superior to radiotherapy alone for the treatment of metastatic epidural spinal cord compression. The current study compared the cost-effectiveness of the two approaches. METHODS AND MATERIALS: In the original clinical trial, clinical effectiveness was measured by ambulation and survival time until death. In this study, an incremental cost-effectiveness analysis was performed from a societal perspective. Costs related to treatment and posttreatment care were estimated and extended to the lifetime of the cohort. Weibull regression was applied to extrapolate outcomes in the presence of censored clinical effectiveness data. RESULTS: From a societal perspective, the baseline incremental cost-effectiveness ratio (ICER) was found to be $60 per additional day of ambulation (all costs in 2003 Canadian dollars). Using probabilistic sensitivity analysis, 50% of all generated ICERs were lower than $57, and 95% were lower than $242 per additional day of ambulation. This analysis had a 95% CI of -$72.74 to 309.44, meaning that this intervention ranged from a financial savings of $72.74 to a cost of $309.44 per additional day of ambulation. Using survival as the measure of effectiveness resulted in an ICER of $30,940 per life-year gained. CONCLUSIONS: We found strong evidence that treatment of metastatic epidural spinal cord compression with surgery in addition to radiotherapy is cost-effective both in terms of cost per additional day of ambulation, and cost per life-year gained.

Patterns of tumor spread and risk of fracture and epidural impingement in metastatic vertebrae.

Among patients with vertebral metastases, the identification of candidates for surgical stabilization has a limited basis in evidence. We retrospectively studied patterns of tumor spread (n = 756 vertebrae) and predictors of fracture and epidural impingement (n = 113 vertebrae) in infiltrated vertebrae with varying tumor histologies using sequential magnetic resonance images. Vertebral bodies were divided into 16 cells to map lesions. Fractured vertebrae were classified based on histology, level, fracture pattern, prefracture infiltration, and epidural impingement. Lesions were most often located within upper lumbar levels and the medial vertebral body. Fracture risk was greatest for upper lumbar (RR = 1.95; 95% CI: 1.12, 3.38) and undifferentiated tumors (RR = 7.36; 95% CI: 2.69, 20.12). A fourfold increase in fracture risk was noted in vertebrae with >80% body infiltration (HR = 4.5966; 95% CI: 1.66, 12.71). Symmetric fractures with fragments had the greatest risk of epidural impingement (p = 0.002). These findings have implications for management of patients with vertebral metastases.